---

---

entities : Eli lilly and company   

save search

---

Lilly Confirms Date and Conference Call for Fourth-Quarter 2023 Financial Results and 2024 Financial Guidance
Published: 2024-01-23 (Crawled : 15:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 19.0% | O: -0.51% H: 0.37% C: 0.32%
conference financial results

---

Rehabilitation Equipment Global Market to Showcase Growth at a CAGR of ~5% by 2028, Examines DelveInsight
Published: 2024-01-22 (Crawled : 23:00) - prnewswire.com
NVRO | $12.07 -2.03% 0.0% 390K |

Health Technology

| -35.35% | O: 2.42% H: 0.0% C: -3.75%
MDT | $79.48 0.37% -0.29% 6.7M |

Health Technology

| -8.55% | O: 0.45% H: 0.58% C: -0.6%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -10.5% | O: -1.11% H: 0.0% C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 19.0% | O: -0.51% H: 0.37% C: 0.32%
BSX | $67.33 -0.13% -0.31% 7M |

Health Technology

| 11.0% | O: 0.1% H: 0.25% C: -0.3%
ABT | News | $107.28 1.91% 0.18% 10M |

Health Technology

| -7.42% | O: -0.07% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -10.99% | O: -2.05% H: 0.0% C: 0.0%
DYNT | $0.52 -6.53% -6.98% 210K |

Health Technology

| 9.26% | O: -1.65% H: 0.0% C: -1.03%
ATEC | $12.54 1.62% 1.59% 1.3M |

Health Technology

| -22.44% | O: 1.07% H: 0.0% C: -0.5%
global growth market

---

Non-Alcoholic Fatty Liver Disease Market to Observe Impressive Growth by 2032, Evaluates DelveInsight | Key Companies - MediciNova, Eli Lilly and Company, AstraZeneca, Madrigal Pharmaceuticals, BioMarin Pharmaceutical, GlaxoSmithKline, Pfizer
Published: 2024-01-22 (Crawled : 22:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 19.0% | O: -0.51% H: 0.37% C: 0.32%
MDGL | $212.33 -4.47% -4.68% 620K |

Health Technology

| -4.68% | O: 1.29% H: 0.35% C: -3.04%
HEPA | News | $2.11 -0.09% -0.09% 73K |

Health Technology

| 0.96% | O: -0.48% H: 7.69% C: 1.44%
ALT | $6.91 0.29% 0.29% 3.6M |

Commercial Services

| -31.37% | O: -0.8% H: 6.02% C: 0.6%
ALNY | $144.315 -0.58% -0.59% 700K |

Health Technology

| -21.07% | O: 0.46% H: 3.04% C: 2.67%
ETNB | $9.08 2.25% 2.2% 1M |

Health Technology

| -13.37% | O: 1.19% H: 0.63% C: -0.72%
liver disease companies key growth market

---

ProQR Highlights New Platform Data from Presentation on Axiomer™ RNA Editing Technology at Deaminet 2024
Published: 2024-01-19 (Crawled : 12:00) - globenewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 20.44% | O: -0.15% H: 1.16% C: 0.99%
PRQR | News | $1.965 5.65% 5.34% 130K |

Health Technology

| -10.38% | O: 2.36% H: 2.76% C: -4.15%
presentation technology platform

---

AAV Vectors in Gene Therapy Market is Predicted to Observe Skyrocketed Growth During the Study Period (2019-2032) | DelveInsight `
Published: 2024-01-16 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -10.78% | O: -1.83% H: 0.0% C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 18.31% | O: 0.77% H: 0.17% C: -1.65%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -11.92% | O: 0.45% H: 0.06% C: -0.5%
RGNX | $15.67 -2.73% -2.87% 570K |

Health Technology

| 11.53% | O: -0.13% H: 0.0% C: -7.15%
ADVM | $11.34 1.7% 1.68% 140K |

Health Technology

| 1338.66% | O: -0.69% H: 2.32% C: -0.12%
therapy growth study market

---

Sjogren's Syndrome Market to Register Sustainable Growth During the Study Period (2019-2032), Predicts DelveInsight | Key Players - Horizon Therapeutics, Dompe Farmaceutici, MorphoSys, Resolve Therapeutics, Novartis, Johnson & Johnson
Published: 2024-01-16 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -10.78% | O: -1.83% H: 0.0% C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -10.48% | O: -1.02% H: 0.0% C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 18.31% | O: 0.77% H: 0.17% C: -1.65%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -11.92% | O: 0.45% H: 0.06% C: -0.5%
IMAB | $1.81 0.56% 0.55% 340K |

Health Technology

| -3.23% | O: -1.08% H: 0.0% C: -8.42%
resolve key growth study market

---

AVEO Oncology Enrolls First Patient in Pivotal FIERCE-HN Clinical Trial to Evaluate Ficlatuzumab in Combination with ERBITUX® (cetuximab) in Patients with HPV-negative Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
Published: 2024-01-16 (Crawled : 12:30) - globenewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 16.78% | O: 0.15% H: 0.59% C: -1.45%
erbitux first cell trial

---

Global Erectile Dysfunction Drugs Market Research Report 2024: Novel Drug Launches Propel Growth, Growing Geriatric Population Drives Demand - Forecast to 2034
Published: 2024-01-16 (Crawled : 00:00) - prnewswire.com
MGRX | $0.286 -4.64% -4.86% 78K |

| -8.2% | O: 3.28% H: 4.38% C: -0.19%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -12.55% | O: -2.03% H: 0.05% C: 0.05%
PTPI | $0.6849 -1.86% -1.9% 150K |

| -47.53% | O: 0.38% H: 0.0% C: -7.58%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 16.78% | O: 0.15% H: 0.59% C: -1.45%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -13.1% | O: -1.34% H: 0.0% C: 0.0%
drug propel report research global growing market

---

Heart Failure Treatment Drug Market to Accelerate Immensely by 2032, Predicts DelveInsight
Published: 2024-01-15 (Crawled : 22:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 16.78% | O: 0.15% H: 0.59% C: -1.45%
drug treatment heart market

---

Global Antibody Fragments Market Research Report 2023: Market to Reach $9.6 Billion by 2028 - Increasing Investments in Biopharmaceuticals Driving Growth
Published: 2024-01-15 (Crawled : 20:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -12.55% | O: -2.03% H: 0.05% C: 0.05%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -13.37% | O: 0.16% H: 0.43% C: 0.07%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 16.78% | O: 0.15% H: 0.59% C: -1.45%
ABBV | $166.41 1.06% 0.0% 5.5M |

Health Technology

| 1.46% | O: -0.49% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -13.1% | O: -1.34% H: 0.0% C: 0.0%
investments report antibody reach research global growth market

---

Gene Therapy Global Market is Projected to Grow at a CAGR of ~19% by 2028, Predicts DelveInsight
Published: 2024-01-12 (Crawled : 22:00) - prnewswire.com
TGTX | $13.79 -1.43% -1.45% 3.7M |

Health Technology

| Email alert Add to watchlist
VRTX | News | $394.43 0.24% 0.24% 1.3M |

Health Technology

| Email alert Add to watchlist
RARE | News F | $42.37 -2.33% -2.38% 680K |

Health Technology

| Email alert Add to watchlist
SLDB | $8.7 -6.05% -6.44% 110K |

Health Technology

| Email alert Add to watchlist
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| Email alert Add to watchlist
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| Email alert Add to watchlist
NVSEF | $93.6375 6.88% 82K |

Health Technology

| Email alert Add to watchlist
BLUE | $1.02 7.03% 6.11% 8.2M |

Health Technology

| Email alert Add to watchlist
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| Email alert Add to watchlist
DTIL | $9.75 -9.05% -9.95% 170K |

Health Technology

| Email alert Add to watchlist
global therapy market

---

Gastroenteropancreatic Neuroendocrine Tumors Market to Showcase a Significant Growth by 2032, Evaluates DelveInsight | Key Players - Eli Lilly and Company, Phanes Therapeutics, Camurus AB, Advanced Accelerator Applications, PharmaMar
Published: 2024-01-11 (Crawled : 22:00) - prnewswire.com
RYZB | $62.49 0.03% 280K |

| 1.11% | O: 0.21% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -11.92% | O: 0.71% H: 0.0% C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 18.1% | O: 0.39% H: 0.91% C: 0.74%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -13.05% | O: 0.06% H: 0.0% C: 0.0%
tumors key advanced growth market

---

Focal Segmental Glomerulosclerosis Market to Observe Impressive Growth by 2032, Predicts DelveInsight | Leading Companies - ACELYRIN, Genentech, ChemoCentryx, Travere Therapeutics, Boehringer Ingelheim, Chinook Therapeutics
Published: 2024-01-10 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -10.95% | O: 1.1% H: 0.0% C: 0.0%
NVO | News | $122.71 -0.03% 0.17% 5M |

Health Technology

| 14.59% | O: -0.33% H: 0.35% C: -1.5%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 19.13% | O: 0.67% H: 0.85% C: 0.21%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -12.45% | O: 0.69% H: 0.0% C: 0.0%
ALDX | $3.865 -2.89% -2.98% 430K |

Health Technology

| 19.16% | O: -1.8% H: 0.46% C: -2.44%
companies therapeutics growth market

---

Innovent Announces the First Phase 3 Clinical Trial of Mazdutide in Chinese Adults with Overweight or Obesity Met the Primary and All Key Secondary Endpoints, and Plans to Submit NDA of Mazdutide to the NMPA
Published: 2024-01-09 (Crawled : 00:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 19.93% | O: 0.65% H: 0.69% C: -0.73%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -11.68% | O: 0.74% H: 0.0% C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M |

Health Technology

| -19.75% | O: 0.0% H: 0.53% C: -2.19%
obesity first chinese key trial

---

NanoImaging Services Appoints John Rigg as Chief Executive Officer
Published: 2024-01-08 (Crawled : 15:00) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M |

Manufacturing

| -51.1% | O: 2.22% H: 0.87% C: -4.35%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 21.38% | O: 0.63% H: 0.58% C: 0.58%
services

---

Mesa Laboratories Appoints Mark Capone to its Board of Directors
Published: 2024-01-08 (Crawled : 13:00) - globenewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 21.38% | O: 0.63% H: 0.58% C: 0.58%
DHR | $235.51 -0.36% 0.0% 2.3M |

Health Technology

| 4.4% | O: -0.56% H: 2.71% C: 2.6%
MLAB | $101.19 1.58% 1.55% 27K |

Health Technology

| 2.23% | O: -0.03% H: 3.71% C: 3.69%

---

Clarivate Identifies Thirteen Potential Blockbuster Drugs and Gamechangers in Annual Drugs to Watch Report
Published: 2024-01-08 (Crawled : 08:00) - prnewswire.com
ALPMF | $9.17 43.47% 16K |

Health Technology

| -22.98% | O: -0.85% H: 1.05% C: 0.08%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -8.67% | O: 2.07% H: 0.48% C: 0.48%
ALPMY | $9.47 -1.11% 520K |

Manufacturing

| -23.19% | O: 0.53% H: 3.97% C: 0.45%
CLVT | $6.99 0.58% 0.0% 4.1M |

Information

| -21.05% | O: 0.92% H: 6.4% C: 5.03%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -9.68% | O: 0.47% H: 0.0% C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 21.38% | O: 0.63% H: 0.58% C: 0.58%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -10.66% | O: 1.16% H: 0.0% C: 0.0%
CALT | $17.65 -2.4% 4K |

Health Technology

| -25.67% | O: 2.68% H: 3.22% C: 0.35%
report potential

---

ISOMORPHIC LABS ANNOUNCES STRATEGIC MULTI-TARGET RESEARCH COLLABORATION WITH LILLY
Published: 2024-01-07 (Crawled : 20:20) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| Email alert Add to watchlist
research collaboration

---

Lilly Launches Direct-to-Consumer Website, Services to Support Weight-Loss Drugs
Published: 2024-01-05 (Crawled : 17:00) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 22.18% | O: -0.08% H: 0.97% C: 0.74%
services

---

Nimbus Therapeutics Announces Expansion of Its Immunology Drug Discovery Pipeline
Published: 2024-01-05 (Crawled : 14:00) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 22.18% | O: -0.08% H: 0.97% C: 0.74%
drug pipeline expansion immunology therapeutics

---

Gainers vs Losers

67%

33%

Top 10 Gainers

AGBA | News | $1.26 215.0% 68.25% 130M |

Finance

EGOX | $0.0515 43.06% 30.1% 330M |

OLB 4 | $0.33 -14.95% 25.53% 840K |

Technology Services

NVFY | $2.77 31.28% 23.83% 33M |

Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M |

Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M |

Distribution Services

INSG | $3.03 25.21% 20.13% 330K |

Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K |

Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M |

ASNS | $0.828 21.75% 17.86% 18K |

---

Your saved searches

---